The clinical cases of ketoacidosis in patients with 2 type diabetes treated with inhibitors of sodium-glucose co-transporter
The diabetic ketoacidosis (DKA) is the most frequent urgent condition in patients with diabetes mellitus which requires hospitalization and results to mortality. The most common causes of DKA are the presence of concomitant diseases in diabetic patients, as well as the violation of the insulin thera...
Saved in:
Main Authors: | Diana Sh. Avzaletdinova (Author), Ilmira Z. Khabibulluna (Author), Olga Y. Ibragimova (Author), Tatiana V. Morugova (Author) |
---|---|
Format: | Book |
Published: |
LLC "MEDIAFORMAT",
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibitors of sodium-glucose cotransporter 2: risk of ketoacidosis
by: T. M. Bukatina, et al.
Published: (2018) -
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment
by: Nunzia D'Onofrio, et al.
Published: (2021) -
Sodium-glucose co-transporter 2 inhibitors - a review article
by: Marcin Makuch, et al.
Published: (2019) -
Sodium-glucose co-transporter 2 inhibitors - a review article
by: Marcin Makuch, et al.
Published: (2019) -
Anti-Arrhythmic Effects of Sodium-Glucose Co-Transporter 2 Inhibitors
by: Yuling Jing, et al.
Published: (2022)